We analyze the potential role of equity injections in addressing insolvency risks among small and medium-sized enterprises (SMEs) after the COVID-19 crisis. Building on firm-level balance sheet projections for a sample of European economies, we simulate selected policy interventions and assess the effectiveness and efficiency of their impact on insolvencies. We find that equity injections are quite effective at dampening the rise in insolvencies. Efficiency requires careful targeting, however; under one illustrative scenario, the cost of a program targeting only those SMEs worth saving is just a tenth of the cost of an untargeted approach directed to all insolvent firms. Overall, our paper provides a case for governments to rely more on targeted equity injections in responding to shocks that trigger mass solvency risks.
Keywords: Insolvency, Bankruptcy, small and medium-sized enterprises, SMEs, equity injections, COVID-19
European Economics: Political Economy & Public Economics eJournal
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
1,115
PAPERS
11,474
This Journal is curated by:
Marco Da Rin at Tilburg University, Department of Finance, Francesco Giavazzi at University of Bocconi - Innocenzo Gasparini Institute for Economic Research (IGIER)National Bureau of Economic Research (NBER)
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
570
PAPERS
6,928
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.